Instituto de Investigación Biomédica da Coruña (INIBIC): Recent submissions

Now showing items 6-10 of 803

    • Molecular states associated with dysfunction and graft loss in heart transplants 

      Halloran, Philip F.; Madill-Thomsen, Katelynn; Mackova, Martina; Aliabadi-Zuckermann, Arezu Z.; Cadeiras, Martin; Crespo-Leiro, María Generosa; Depasquale, Eugene C.; Deng, Mario; Gökler, Johannes; Hall, Shelley A.; Kim, Daniel H.; Kobashigawa, Jon; Macdonald, Peter; Potena, Luciano; Shah, Keyur; Stehlik, Josef; Zuckermann, Andreas; Reeve, Jeff (Elsevier, 2023-11-30)
      [Abstract] Background: We explored the changes in gene expression correlating with dysfunction and graft failure in endomyocardial biopsies. Methods: Genome-wide microarrays (19,462 genes) were used to define mRNA ...

    • A multitrait genetic study of hemostatic factors and hemorrhagic transformation after stroke treatment 

      Gallego-Fábrega, Cristina; Temprano-Sagrera, Gerard; Cárcel-Márquez, Jara; Muiño, Elena; Cullel, Natalia; Lledós, Miquel; Llucià-Carol, Laia; Martín-Campos, Jesús M.; Sobrino, Tomás; Castillo, José; Millán, Mónica; Muñoz-Narbona, Lucía; López-Cancio Martínez, Elena; Ribó, Marc; Álvarez-Sabín, José; Jiménez-Conde, Jordi; Roquer, Jaume; Tur, Silvia; Obach, Victor; Arenillas, Juan; Segura, Tomás; Serrano-Heras, Gemma; Martí-Fàbregas, Joan; Freijo Guerrero, María del Mar; Moniche Álvarez, Francisco; Castellanos, María del Mar; Morrison, Alana C.; Smith, Nicholas L.; de Vries, Paul S.; Fernández-Cadenas, Israel; Sabater-Lleal, María (Elsevier, 2023-12-15)
      [Abstract] Background: Thrombolytic recombinant tissue plasminogen activator (r-tPA) treatment is the only pharmacologic intervention available in the ischemic stroke acute phase. This treatment is associated with an ...

    • Impact of COVID-19 outbreak on ischemic stroke admissions and in-hospital mortality in North-West Spain 

      Tejada Meza, Herbert; Lambea Gil, Álvaro; Sancho Saldaña, Agustín; Martínez-Zabaleta, Maite; de la Riva, Patricia; López-Cancio Martínez, Elena; Castañón Apilánez, María; Herrera Isasi, María; Marta Enguita, Juan; Lera Alfonso, Mercedes de; Arenillas, Juan; Segurola Olaizaola, Jon; Timiraos Fernández, Juan José; Sánchez, Joaquín; Castellanos, María del Mar; Roel, Alexia; Casado Menéndez, Ignacio; Freijo Guerrero, María del Mar; Luna, Alain; Palacio-Portilla, Enrique Jesús; Jiménez López, Yésica; Rodríguez Castro, Emilio; Arias Rivas, Susana; Tejada García, Javier; Beltrán Rodríguez, Iria; Julián Villaverde, Francisco; Moreno García, María Pilar; Trejo-Gabriel-Galán, José María; Echevarría Íñiguez, Ana; Tejero Juste, Carlos; Pérez Lázaro, Cristina; Marta Moreno, Javier (Sage, 2020-06-11)
      [Abstract] Background and purpose: Spain has been one of the countries heavily stricken by COVID-19. But this epidemic has not affected all regions equally. We analyzed the impact of the COVID-19 pandemic on hospital ...

    • Oral anticoagulation and risk of symptomatic hemorrhagic transformation in stroke patients treated with mechanical thrombectomy: data from the nordictus registry 

      Ramos-Araque, María E.; Chavarría-Miranda, Alba; Gómez-Vicente, Beatriz; López-Cancio Martínez, Elena; Castañón Apilánez, María; Castellanos, María del Mar; López Fernández, María; Tejada Meza, Herbert; Marta Moreno, Javier; Tejada García, Javier; Beltrán Rodríguez, Iria; de la Riva, Patricia; Díez, Noemí; Arias Rivas, Susana; Santamaría Cadavid, María; Bravo Anguiano, Yolanda; Bártulos Iglesias, Mónica; Palacio-Portilla, Enrique Jesús; Revilla García, Marian; Timiraos Fernández, Juan José; Arenaza Basterrechea, Naroa; Maciñeiras Montero, José Luis; Vicente Alba, Pablo; Julián Villaverde, Francisco José; Pinedo Brochado, Ana; Azkune, Itxaso; Freijo Guerrero, María del Mar; Luna, Alain; Arenillas, Juan (Frontiers, 2020-11-26)
      [Abstract] Introduction: We aimed to evaluate if prior oral anticoagulation (OAC) and its type determines a greater risk of symptomatic hemorrhagic transformation in patients with acute ischemic stroke (AIS) subjected to ...

    • Use of cardiovascular polypills for the secondary prevention of cerebrovascular disease 

      Masjuan, Jaime; Gállego, Jaime; Aguilera, José María; Arenillas, Juan; Castellanos, María del Mar; Díaz, Fernando; Portilla, Juan Carlos; Purroy, Francesc (Elsevier, 2019-08-11)
      [Abstract] Introduction: There is little control of cardiovascular (CV) risk factors in secondary prevention after an ischaemic stroke, in part due to a lack of adherence to treatment. The CV polypill may contribute ...